Liver enzymes among COVID-19 patients in Al-Ahsa region of Saudi Arabia.
BMJ Open Gastroenterol
; 10(1)2023 04.
Artículo
en Inglés
| MEDLINE | ID: covidwho-2291082
ABSTRACT
BACKGROUND:
Hepatic damage is one of the common forms of extra pulmonary organ destructions among patients with COVID-19 infections.AIM:
To evaluate the prognosis of liver damage among COVID-19 patients based on their liver enzymes profile.METHODS:
A retrospective study was done to evaluate the records of the hospitably admitted patient due to COVID-19 infection.Retrieved data included clinical presentation and investigation either imaging or laboratory with special investing in liver function tests.RESULT:
We reviewed 442 patients who were diagnosed with COVID-19 infection.They were 64.5% of female patients and 35.5% of male patients. Their mean age was 54.5%, most of them were Saudi (76.7%) and the overall mortality reached up to (20.4%).CONCLUSION:
This large cohort of 442 patients has shown that liver damage may be an independent prognostic factor for morbidities and mortality among COVID-19 patients. It also showed the importance of liver function enzymes screening as a predictor for the outcome of those patients.Palabras clave
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Asunto principal:
COVID-19
/
Hepatopatías
Tipo de estudio:
Estudio de cohorte
/
Estudio experimental
/
Estudio observacional
/
Estudio pronóstico
Límite:
Femenino
/
Humanos
/
Masculino
/
Middle aged
País/Región como asunto:
Asia
Idioma:
Inglés
Año:
2023
Tipo del documento:
Artículo
País de afiliación:
Bmjgast-2023-001121
Similares
MEDLINE
...
LILACS
LIS